Acer Therapeutics Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$16.2M

414 transactions

Summary

Acer Therapeutics Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $11.8MSales: $1.2M54 insiders

Date	Insider	Type	Value
2022-11-29	Schelling Chris(President & CEO)	Buy	$1000K
2022-11-29	ASELAGE STEVE	Buy	$500K
2023-11-17	Davis Jefferson E(CHIEF BUSINESS OFFICER)	D	—
2023-11-17	PALMIN HARRY S(CHIEF FINANCIAL OFFICER)	D	—
2023-11-17	Schelling Chris(PRESIDENT AND CEO)	D	—
2023-11-17	Joseph Donald(See Remarks)	D	—
2023-11-17	DUNN JOHN MICHAEL	D	—
2023-11-17	ASELAGE STEVE	D	—
2023-03-14	Amello Jason	A	$0
2023-03-14	ASELAGE STEVE	A	$0
2023-03-14	Davis Jefferson E(Chief Business Officer)	A	$0
2023-03-14	DUNN JOHN MICHAEL	A	$0
2023-03-14	GRIFFIN MICHELLE RENEE	A	$0
2023-03-14	Hayden Tanya(Chief Operating Officer)	A	$0
2023-03-14	Joseph Donald(Chief Legal Officer and Secy)	A	$0
2023-03-14	Klopp John Michael(Chief Technical Officer)	A	$0
2023-03-14	PALMIN HARRY S(Chief Financial Officer)	A	$0
2023-03-14	Paul Bernard H(Chief People Officer)	A	$0
2023-03-14	Quartel Adrian W(Chief Medical Officer)	A	$0
2022-06-19	Hayden Tanya(Chief Operating Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Acer Therapeutics Inc. — Contributions, Lobbying & Contracts | Poliscope